Go Pro
NASDAQ:ACOG

Alpha Cognition Q2 2026 Earnings Report

Alpha Cognition logo
$7.98 -0.25 (-3.06%)
As of 02:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Alpha Cognition EPS Results

Actual EPS
N/A
Consensus EPS
-$0.39
Beat/Miss
N/A
One Year Ago EPS
N/A

Alpha Cognition Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.38 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Alpha Cognition Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, August 13, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Alpha Cognition Earnings Headlines

Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
See More Alpha Cognition Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Cognition? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Cognition and other key companies, straight to your email.

About Alpha Cognition

Alpha Cognition (NASDAQ:ACOG), Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

View Alpha Cognition Profile